Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRIB
2001
Trinity Biotech
TRIB
$8.61M
| $2.38M | 0.01% |
1,347
-114
| -8% | -$202K |
|
2002
Applied Industrial Technologies
AIT
$12.6B
| $2.35M | 0.01% |
58,150
+25,300
| +77% | +$1.03M |
|
|
MBTF
2003
DELISTED
MBT Financial Corporation
MBTF
| $2.34M | 0.01% |
342,856
+10,809
| +3% | +$69.8K |
|
|
SIFI
2004
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
| $2.34M | 0.01% |
171,279
+17,779
| +12% | +$228K |
|
|
NSH
2005
DELISTED
NuStar GP Holdings LLC
NSH
| $2.34M | 0.01% |
110,500
-18,471
| -14% | -$446K |
|
2006
MillerKnoll
MLKN
$1.53B
| $2.34M | 0.01% |
81,400
+50,700
| +165% | +$1.56M |
|
|
LSG
2007
DELISTED
LAKE SHORE GOLD CORP
LSG
| $2.33M | 0.01% |
2,878,898
+810,500
| +39% | +$670K |
|
2008
Consumer Portfolio Services
CPSS
$208M
| $2.32M | 0.01% |
447,200
-28,100
| -6% | -$144K |
|
2009
Lipocine
LPCN
$17.4M
| $2.32M | 0.01% |
10,541
-3,559
| -25% | -$747K |
|
|
BCA
2010
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $2.31M | 0.01% |
197,472
+17,306
| +10% | +$227K |
|
|
CHA
2011
DELISTED
China Telecom Corporation, LTD
CHA
| $2.31M | 0.01% |
49,700
-16,500
| -25% | -$823K |
|
2012
New Jersey Resources
NJR
$5.91B
| $2.31M | 0.01% |
70,000
-70,122
| -50% | -$2.15M |
|
2013
Natural Alternatives International
NAII
$15.2M
| $2.3M | 0.01% |
222,760
+23,660
| +12% | +$173K |
|
2014
Chubb
CB
$135B
| $2.3M | 0.01% |
19,700
-550,300
| -97% | -$62.3M |
|
|
SCAI
2015
DELISTED
Surgical Care Affiliates, Inc.
SCAI
| $2.3M | 0.01% |
57,827
+3,927
| +7% | +$137K |
|
|
POWR
2016
DELISTED
POWERSECURE INTL INC COM STK (DE)
POWR
| $2.3M | 0.01% |
152,600
+32,600
| +27% | +$437K |
|
2017
Corcept Therapeutics
CORT
$12.7B
| $2.29M | 0.01% |
460,400
+8,200
| +2% | +$37K |
|
2018
Mitek Systems
MITK
$771M
| $2.29M | 0.01% |
+557,976
| New | +$2.24M |
|
|
TGP
2019
DELISTED
Teekay LNG Partners L.P.
TGP
| $2.29M | 0.01% |
174,300
+78,920
| +83% | +$1.72M |
|
|
NP
2020
DELISTED
Neenah, Inc. Common Stock
NP
| $2.29M | 0.01% |
36,700
-8,700
| -19% | -$561K |
|
2021
IRIDEX
IRIX
$14.5M
| $2.29M | 0.01% |
246,400
-8,500
| -3% | -$75.8K |
|
2022
SK Telecom
SKM
$12.2B
| $2.29M | 0.01% |
68,884
+11,401
| +20% | +$429K |
|
|
CYBE
2023
DELISTED
Cyberoptics Corp
CYBE
| $2.28M | 0.01% |
298,200
-900
| -0.3% | -$6.47K |
|
|
JMI
2024
DELISTED
JAVELIN MTG INVESTMENT CORP COM
JMI
| $2.28M | 0.01% |
363,100
+54,200
| +18% | +$341K |
|
2025
Willdan Group
WLDN
$1.06B
| $2.28M | 0.01% |
271,600
+5,951
| +2% | +$59.3K |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.